In addition, PTPN11 mutation has also been demonstrated to be harmful to myocardial hypertrophy and cardiac fibrotic remodeling through crosstalking with NF-κB pathway and mTOR signaling (Schramm et al., 2012; Zhou et al., 2020a). Here, MTOR is linked to cardiac hypertrophy.